危重患者院内转运期间的不良事件:系统评价与Meta分析
该系统评价与Meta分析检索MEDLINE和Cochrane Central Register of Controlled Trials(截至2020年6月3日)以及国际临床试验平台检索门户和ClinicalTrials.gov,纳入24项英文前瞻性或回顾性队列研究,共12,313次院内转运、1898例患者。主要结局为院内转运期间全部不良事件的发生率,合并频率为26.2%(95%CI 15.0-39.2),研究间异质性高(I2=99.5%);因院内转运死亡和危及生命不良事件的合并频率各为0%和1.47%,异质性亦高。作者认为不良事件可发生于危重患者院内转运期间,但严重不良事件频率相对较低,该结果可辅助评估需院内转运的诊断或治疗操作的风险获益。
要点
- 24项研究、12,313次院内转运、1898例患者,院内转运期间全部不良事件合并频率26.2%(95%CI 15.0-39.2),异质性高(I2=99.5%)。
- 因院内转运死亡的合并频率为0%,危及生命不良事件的合并频率为1.47%,异质性亦高。
- 作者认为危重患者院内转运期间可发生不良事件,但严重不良事件频率相对较低。
- 该Meta分析结果可辅助评估需院内转运的诊断或治疗操作的风险获益。
适用人群与场景
- 危重患者,因诊断性操作、治疗性操作或收入重症监护病房而需院内转运。
研究设计与关键结果
- 系统评价与Meta分析,纳入24项英文前瞻性或回顾性队列研究,共12,313次院内转运、1898例患者。
- 主要结局全部不良事件的合并频率为26.2%(95%CI 15.0-39.2),异质性高(I2=99.5%)。
- 因院内转运死亡的合并频率为0%,危及生命不良事件的合并频率为1.47%,异质性亦高。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入前瞻性和回顾性队列研究。
- 局限:原文报告异质性高(全部不良事件I2=99.5%;死亡和危及生命不良事件异质性亦高)。
对床旁实践的改变
- 作者认为不良事件可发生于危重患者院内转运期间,但严重不良事件频率相对较低。
- 作者认为该Meta分析结果可辅助评估需院内转运的诊断或治疗操作的风险获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Intrahospital transport of critically ill patients is often necessary for diagnostic procedures, therapeutic procedures, or admission to the intensive care unit. The aim of this study was to investigate and describe safety and adverse events during intrahospital transport of critically ill patients.
MATERIAL AND METHODS: A systematic search was performed of MEDLINE and the Cochrane Central Register of Controlled Trials for studies published up to June 3, 2020, and of the International Clinical Trials Platform Search Portal and ClinicalTrials.gov for ongoing trials. We selected prospective and retrospective cohort studies published in English on intrahospital transport of critically ill patients, and then performed a meta-analysis. The primary outcome was the incidence of all adverse events that occurred during intrahospital transport. The secondary outcomes were death due to intrahospital transport or life-threatening adverse events, minor events in vital signs, adverse events related to equipment, durations of ICU and hospital stay, and costs.
RESULTS: A total of 12,313 intrahospital transports and 1898 patients from 24 studies were included in the meta-analysis. Among 24 studies that evaluated the primary outcome, the pooled frequency of all adverse events was 26.2% (95% CI: 15.0-39.2) and the heterogeneity among these studies was high (I2 = 99.5%). The pooled frequency of death due to intrahospital transport and life-threatening adverse events was 0% and 1.47% each, but heterogeneity was also high.
CONCLUSIONS: Our findings suggest that adverse events can occur during intrahospital transport of critically ill patients, and that the frequency of critical adverse events is relatively low. The results of this meta-analysis could assist in risk-benefit analysis of diagnostic or therapeutic procedures requiring intrahospital transport of critically ill patients.
TRIAL REGISTRATION: UMIN000040963.
参考来源
- Murata M, Nakagawa N, Kawasaki T, et al. Adverse events during intrahospital transport of critically ill patients: A systematic review and meta-analysis. Am J Emerg Med. 2021. PMID: 34861515. doi:10.1016/j.ajem.2021.11.021
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。